Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
wubi shanyao pill
- Development stage
- Phase 4
- Lead developer
- Huqing Yutang
- Administration
- Oral
01
Overview
Wubi Shanyao Pill is a Traditional Chinese Medicine (TCM) herbal formula traditionally used to treat kidney-related conditions, particularly those characterized by spleen and kidney deficiency. The formula typically comprises several botanical ingredients, including *Dioscorea opposita* (Shanyao), *Rehmannia glutinosa*, *Cistanche deserticola*, *Cuscuta chinensis*, *Poria cocos*, *Achyranthes bidentata*, and *Alisma plantago-aquatica*. In modern clinical research, it is being investigated for its potential to reduce proteinuria and slow the progression of kidney failure in patients with IgA nephropathy who are at moderate to high risk of renal decline. The formula is thought to exert its therapeutic effects through multi-target mechanisms involving immunomodulation and anti-inflammatory pathways, although specific molecular targets for the entire combination are not fully defined in a Western pharmacological context.
- Other names
- Wubi Shanyao WanWubishanyao PillWubishanyao Wan
02
Targets
FOXO3 (Forkhead box protein O3)PCNA (Proliferating cell nuclear antigen)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)SIRT3 (NAD-dependent protein deacetylase sirtuin-3)TP53 (Cellular Tumor Antigen p53 R175H)
Beyond the preview
Go deeper on wubi shanyao pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on wubi shanyao pill.